CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock Purchase Agreement	At Market Issuance Sales Agreement	Common Stock	Common Stock Common Stock Purchase Agreement	Common Stock At Market Issuance Sales Agreement	Additional Paid-in Capital	Additional Paid-in Capital Common Stock Purchase Agreement	Additional Paid-in Capital At Market Issuance Sales Agreement	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022				84,610,114
Beginning balance at Dec. 31, 2022	$ 73,033			$ 8			$ 165,912			$ (92,887)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with the Stock Purchase Agreement/At Market Issuance Sales Agreement, net of issuance cost (in shares)					2,952,763	89,383
Issuance of common stock in connection with the Stock Purchase Agreement/At Market Issuance Sales Agreement, net of issuance cost		$ 18,982	$ 370		$ 1			$ 18,981	$ 370
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)				1,217,103
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	310						310
Exercise of stock warrants (in shares)				100
Issuance of common stock upon exercise of stock warrants, net of issuance cost	1						1
Stock-based compensation	3,880						3,880
Net loss	$ (36,776)									(36,776)
Ending balance (in shares) at Dec. 31, 2023	88,869,463			88,869,463
Ending balance at Dec. 31, 2023	$ 59,800			$ 9			189,454			(129,663)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with the Stock Purchase Agreement/At Market Issuance Sales Agreement, net of issuance cost (in shares)						14,701,388
Issuance of common stock in connection with the Stock Purchase Agreement/At Market Issuance Sales Agreement, net of issuance cost			$ 33,263			$ 2			$ 33,261
Cancellation and retirement of common stock (in shares)				(5,500,000)
Cancellation and retirement of common stock	0			$ (1)			1
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)				2,714,599
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	109						109
Exercise of stock warrants (in shares)				13,075,664
Issuance of common stock upon exercise of stock warrants, net of issuance cost	13,628			$ 2			13,626
Issuance of common stock upon exchange of stock warrants for shares of common stock (in shares)				3,073,200
Stock-based compensation	7,343						7,343
Net loss	$ (44,671)									(44,671)
Ending balance (in shares) at Dec. 31, 2024	116,934,314			116,934,314
Ending balance at Dec. 31, 2024	$ 69,472			$ 12			$ 243,794			$ (174,334)